Sun Pharmaceutical Industries share news, announcements and annual reports
NSE: SUNPHARMABSE: 524715Pharmaceuticals & BiotechnologyLarge Cap
Sun Pharmaceutical Industries Limited · Formerly Sun Pharmaceuticals Industries · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1994 on BSE, Feb 1995 on NSE
Last close ₹1,761.00up ₹3.50 (0.20%)BSE ₹1,762.95
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,757.50.
29 Oct: open ₹1,757.50, high ₹1,771.50, low ₹1,752.70
52-week range of traded prices to 29 Oct 2026
₹1,583.70Low, 29 Jan 2026₹2,046.90High, 31 Jul 2026
- Next results date: the board meets on 30 Oct 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,22,523 Cr13th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 34.93
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.06
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.91%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 16.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.05
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 11,07,85459.5% delivered
Sun Pharmaceutical Industries routine notices
313 filed, newest first. Page 1 of 7.
Oct 2026
Sep 2026
Aug 2026
26 Aug · Routine
1 Aug · Routine
Jul 2026
7 Jul · Routine
Jun 2026
26 Jun · Routine
May 2026
Apr 2026
8 Apr · Routine
Mar 2026
18 Mar · Routine
Feb 2026
1 Feb · Routine
Jan 2026
Dec 2025
23 Dec · Routine
Nov 2025
6 Nov · Routine
Oct 2025
31 Oct · Routine
Sep 2025
Aug 2025
1 Aug · Routine
Jul 2025
15 Jul · Routine
Jun 2025
Apr 2025
Mar 2025
Jan 2025
Dec 2024
17 Dec · Routine
10 Dec · Routine
Nov 2024
28 Nov · Routine
11 Nov · Routine
Oct 2024
10 Oct · Routine
9 Oct · Routine
8 Oct · Routine
Sep 2024
25 Sep · Routine
20 Sep · Routine
18 Sep · Routine
13 Sep · Routine